Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285173831> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4285173831 endingPage "202" @default.
- W4285173831 startingPage "195" @default.
- W4285173831 abstract "Introduction: Vasculitis associated with anti-neutrophil cytoplasm antibodies (ANCA) can be grouped with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MAP), and eosinophilic granulomatosis with polyangiitis (EGPA). Diagnosis of these rare pathologies is based on clinical presentation, the positivity of ANCA, and, if possible, histological proof of vasculitis. Our study describes a series of six cases of ANCA-associated vasculitis where due to the severity of symptoms apheresis sessions were started from the beginning of the therapy. Patients and methods: We conducted a retrospective, single-center observational, monocentric study on all patients treated by apheresis for ANCA vasculitis in the period January 01, 2016 to December 01, 2019. Results: We identified six cases of ANCA vasculitis treated by apheresis over a 3-year period. The mean age was 61 ± 19 years; M/F gender ratio was 1:1. Initial renal damage in all patients was rapidly progressive glomerulonephritis. Inflammatory syndrome occurred in all patients with average CRP of 82 mg/L. All patients had positive ANCA at diagnosis. Four patients required renal replacement therapy at the time of diagnosis. The induction regimen consisted of rituximab associated with IV boluses of methylprednisolone. The apheresis techniques used were the same for all patients, i.e. plasmapheresis. Outcomes were favorable for five patients; only one patient became dependent on hemodialysis. No mortality occurred. Conclusion: This study analyzed practices for the management of patients with ANCA vasculitis. No patient was treated with cyclophosphamide as a first approach but rituximab instead. Plasmapheresis was given because of symptoms severity at initial diagnosis." @default.
- W4285173831 created "2022-07-14" @default.
- W4285173831 creator A5048173261 @default.
- W4285173831 creator A5066608092 @default.
- W4285173831 creator A5077289325 @default.
- W4285173831 creator A5086033107 @default.
- W4285173831 creator A5087177686 @default.
- W4285173831 creator A5090613014 @default.
- W4285173831 date "2022-01-01" @default.
- W4285173831 modified "2023-09-30" @default.
- W4285173831 title "ANCA-Associated Vasculitis: Value of Apheresis in Initial Treatment" @default.
- W4285173831 doi "https://doi.org/10.4236/ojneph.2022.122019" @default.
- W4285173831 hasPublicationYear "2022" @default.
- W4285173831 type Work @default.
- W4285173831 citedByCount "0" @default.
- W4285173831 crossrefType "journal-article" @default.
- W4285173831 hasAuthorship W4285173831A5048173261 @default.
- W4285173831 hasAuthorship W4285173831A5066608092 @default.
- W4285173831 hasAuthorship W4285173831A5077289325 @default.
- W4285173831 hasAuthorship W4285173831A5086033107 @default.
- W4285173831 hasAuthorship W4285173831A5087177686 @default.
- W4285173831 hasAuthorship W4285173831A5090613014 @default.
- W4285173831 hasBestOaLocation W42851738311 @default.
- W4285173831 hasConcept C126322002 @default.
- W4285173831 hasConcept C141071460 @default.
- W4285173831 hasConcept C159654299 @default.
- W4285173831 hasConcept C203014093 @default.
- W4285173831 hasConcept C2775998817 @default.
- W4285173831 hasConcept C2776015282 @default.
- W4285173831 hasConcept C2776738589 @default.
- W4285173831 hasConcept C2778063415 @default.
- W4285173831 hasConcept C2778842783 @default.
- W4285173831 hasConcept C2778910314 @default.
- W4285173831 hasConcept C2779134260 @default.
- W4285173831 hasConcept C2779338263 @default.
- W4285173831 hasConcept C2780653079 @default.
- W4285173831 hasConcept C2781229154 @default.
- W4285173831 hasConcept C71924100 @default.
- W4285173831 hasConcept C89560881 @default.
- W4285173831 hasConcept C90924648 @default.
- W4285173831 hasConceptScore W4285173831C126322002 @default.
- W4285173831 hasConceptScore W4285173831C141071460 @default.
- W4285173831 hasConceptScore W4285173831C159654299 @default.
- W4285173831 hasConceptScore W4285173831C203014093 @default.
- W4285173831 hasConceptScore W4285173831C2775998817 @default.
- W4285173831 hasConceptScore W4285173831C2776015282 @default.
- W4285173831 hasConceptScore W4285173831C2776738589 @default.
- W4285173831 hasConceptScore W4285173831C2778063415 @default.
- W4285173831 hasConceptScore W4285173831C2778842783 @default.
- W4285173831 hasConceptScore W4285173831C2778910314 @default.
- W4285173831 hasConceptScore W4285173831C2779134260 @default.
- W4285173831 hasConceptScore W4285173831C2779338263 @default.
- W4285173831 hasConceptScore W4285173831C2780653079 @default.
- W4285173831 hasConceptScore W4285173831C2781229154 @default.
- W4285173831 hasConceptScore W4285173831C71924100 @default.
- W4285173831 hasConceptScore W4285173831C89560881 @default.
- W4285173831 hasConceptScore W4285173831C90924648 @default.
- W4285173831 hasIssue "02" @default.
- W4285173831 hasLocation W42851738311 @default.
- W4285173831 hasOpenAccess W4285173831 @default.
- W4285173831 hasPrimaryLocation W42851738311 @default.
- W4285173831 hasRelatedWork W2012258251 @default.
- W4285173831 hasRelatedWork W2900094522 @default.
- W4285173831 hasRelatedWork W2993793844 @default.
- W4285173831 hasRelatedWork W3040579482 @default.
- W4285173831 hasRelatedWork W3197765824 @default.
- W4285173831 hasRelatedWork W3210213926 @default.
- W4285173831 hasRelatedWork W4224442774 @default.
- W4285173831 hasRelatedWork W4280507957 @default.
- W4285173831 hasRelatedWork W4285173831 @default.
- W4285173831 hasRelatedWork W73125220 @default.
- W4285173831 hasVolume "12" @default.
- W4285173831 isParatext "false" @default.
- W4285173831 isRetracted "false" @default.
- W4285173831 workType "article" @default.